- Home
- USAS vs ATAI Comparison
USAS vs ATAI Comparison
Compare USAS & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAS
- ATAI
- Stock Information
- Founded
- USAS 1998
- ATAI 2018
- Country
- USAS Canada
- ATAI Germany
- Employees
- USAS N/A
- ATAI N/A
- Industry
- USAS Metal Mining
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- USAS Basic Materials
- ATAI Health Care
- Exchange
- USAS Nasdaq
- ATAI Nasdaq
- Market Cap
- USAS 286.7M
- ATAI 271.6M
- IPO Year
- USAS N/A
- ATAI 2021
- Fundamental
- Price
- USAS $0.58
- ATAI $1.39
- Analyst Decision
- USAS Strong Buy
- ATAI Strong Buy
- Analyst Count
- USAS 1
- ATAI 4
- Target Price
- USAS $0.90
- ATAI $9.00
- AVG Volume (30 Days)
- USAS 1.1M
- ATAI 2.1M
- Earning Date
- USAS 05-14-2025
- ATAI 03-17-2025
- Dividend Yield
- USAS N/A
- ATAI N/A
- EPS Growth
- USAS N/A
- ATAI N/A
- EPS
- USAS N/A
- ATAI N/A
- Revenue
- USAS $97,123,000.00
- ATAI $308,000.00
- Revenue This Year
- USAS $21.84
- ATAI N/A
- Revenue Next Year
- USAS $46.00
- ATAI $20.00
- P/E Ratio
- USAS N/A
- ATAI N/A
- Revenue Growth
- USAS 14.33
- ATAI N/A
- 52 Week Low
- USAS $0.20
- ATAI $0.78
- 52 Week High
- USAS $0.60
- ATAI $2.85
- Technical
- Relative Strength Index (RSI)
- USAS 63.78
- ATAI 39.19
- Support Level
- USAS $0.45
- ATAI $1.34
- Resistance Level
- USAS $0.56
- ATAI $1.52
- Average True Range (ATR)
- USAS 0.04
- ATAI 0.11
- MACD
- USAS 0.01
- ATAI -0.02
- Stochastic Oscillator
- USAS 97.93
- ATAI 16.87
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets are The Cosala operations, The Galena Complex, and Relief Canyon. The company also holds interests in the San Felipe Development Project located in Sonora, Mexico. It has geographic focus is the Western Hemisphere, particularly the United States and Mexico.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.